Abstract
Background:
D-dimer has been used to rule out pulmonary embolism (PE). Based on previous reports of decreased concentrations of coagulation factor XIII (FXIII) in venous thromboembolism, and no change in FXIII concentration in patients with acute cardiovascular disease, we evaluated the benefit of simultaneously measuring D-dimer and FXIII concentrations for diagnosing PE.
Methods:
In this prospective single-center study, we enrolled 209 patients initially suspected of having PE, and measured their D-dimer and FXIII concentrations. Forty-one patients were diagnosed with PE and 168 with other final diagnoses, including acute coronary syndrome (ACS); aortic dissection (AD); spontaneous pneumothorax (SP); other respiratory, heart, digestive and nervous diseases; and uncertain diagnoses.
Results:
Patients with PE had significantly higher D-dimer and lower FXIII concentrations than did patients without PE. Combined D-dimer and FXIII measurements provided a higher positive predictive value (76.6%) for PE than single tests, especially in patients with Wells score >4.0 (89.3%). Specifically, patients with AD or ACS showed higher FXIII concentrations and mean platelet volumes than did patients with PE or SP, and patients with PE and AD had higher D-dimer concentrations than did other patients. At the thresholds of 69.0% for FXIII and 1.10 μg/mL for D-dimer, 123/151 patients (81.5%) with serious diseases (PE, AD, ACS and SP) were correctly distinguished.
Conclusions:
Combined measurement of D-dimer and FXIII helps distinguish PE from serious diseases with similar symptoms and appears to relate to increased FXIII release from active platelets in cardiovascular disease.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This study was supported by grants from the Natural Science Foundation of China (Grant No. 81200353).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Wells PS, Ginsberg JS, Anderson DR, Kearon C, Gent M, Turpie AG, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998;129:997–1005.10.7326/0003-4819-129-12-199812150-00002Search in Google Scholar PubMed
2. Di Nisio M, Squizzato A, Rutjes AW, Buller HR, Zwinderman AH, Bossuyt PM. Diagnostic accuracy of d-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 2007;5:296–304.10.1111/j.1538-7836.2007.02328.xSearch in Google Scholar PubMed
3. Suzuki T, Distante A, Zizza A, Trimarchi S, Villani M, Salerno Uriarte JA, et al. Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation 2009;119:2702–7.10.1161/CIRCULATIONAHA.108.833004Search in Google Scholar PubMed
4. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 1999;94:271–305.10.1016/S0049-3848(99)00023-7Search in Google Scholar PubMed
5. Kucher N, Schroeder V, Kohler HP. Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness. Thromb Haemost 2003;90:434–8.10.1160/TH03-07-0031Search in Google Scholar PubMed
6. Knudsen JB, Gormsen J, Skagen K, Amtorp O. Changes in platelet functions, coagulation and fibrinolysis in uncomplicated cases of acute myocardial infarction. Thromb Haemost 1980;42:1513–22.10.1055/s-0038-1657053Search in Google Scholar PubMed
7. Ilkhanipour K, Wolfson AB, Walker H, Cillo J, Rolniak S, Cockley P, et al. Combining clinical risk with D-dimer testing to rule out deep vein thrombosis. J Emerg Med 2004;27:233–9.10.1016/j.jemermed.2004.04.010Search in Google Scholar PubMed
8. Kelly J, Hunt BJ. The utility of pretest probability assessment in patients with clinically suspected venous thromboembolism. J Thromb Haemost 2003;1:1888–96.10.1046/j.1538-7836.2003.00382.xSearch in Google Scholar PubMed
9. Muszbek L, Bereczky Z, Bagoly Z, Komáromi I, Katona É. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 2011;91:931–72.10.1152/physrev.00016.2010Search in Google Scholar PubMed
10. Board PG, Losowsky MS, Miloszewski KJ. Factor XIII: inherited and acquired deficiency. Blood Rev 1993;7:229–42.10.1016/0268-960X(93)90010-2Search in Google Scholar PubMed
11. Kłoczko J, Wojtukiewicz M, Bielawiec M, Zarzycka B, Kinalska I. Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy. Acta Haematol 1986;76:81–5.10.1159/000206026Search in Google Scholar PubMed
12. AbdAlla S, Lother H, Langer A, el Faramawy Y, Quitterer U. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 2004;119:343–54.10.1016/j.cell.2004.10.006Search in Google Scholar PubMed
13. Robinson BR, Houng AK, Reed GL. Catalytic life of activated factor XIII in thrombi. Implications for fibrinolytic resistance and thrombus aging. Circulation 2000;102:1151–7.10.1161/01.CIR.102.10.1151Search in Google Scholar PubMed
14. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systemic review and meta-analysis. J Thromb Haemost 2010;8:148–56.10.1111/j.1538-7836.2009.03584.xSearch in Google Scholar PubMed PubMed Central
15. Ihara A, Matsumoto K, Kawamoto T, Shouno S, Kawamoto J, Katayama A, et al. Evaluation of platelet indexes in patients with aortic aneurysm. Pathophysiol Haemost Thromb 2005;34:269–73.10.1159/000093106Search in Google Scholar PubMed
16. Sbarouni E, Georgiadou P, Analitis A, Voudris V. Significant changes in platelet count, volume and size in acute aortic dissection. Int J Cardiol 2013;168:4349–50.10.1016/j.ijcard.2013.05.074Search in Google Scholar PubMed
17. Lippi G, Filippozzi L, Salvagno GL, Montagnana M, Franchini M, Guidi GC. Increased mean platelet volume in patients with acute coronary syndromes. Arch Pathol Lab Med 2009;133:1441–3.10.5858/133.9.1441Search in Google Scholar PubMed
18. Murata A, Kouno A, Yamamoto K, Yoshioka H, Kida K, Kudoh S. The treatment of refractory pneumothorax in diffuse panbronchiolitis by intravenous administration of coagulation factor XIII concentrate. J Nippon Med Sch 2006;73: 89–92.10.1272/jnms.73.89Search in Google Scholar PubMed
19. Ueda H, Iwasaki A, Kusano T. Use of plasma factor XIII in a patient with prolonged parenchymal air leak – a case report. Med Bull Fukuoka Univ 1992;19:473–5.Search in Google Scholar
20. Muszbek L, Bereczky Z, Bagoly Z, Shemirani AH, Katona E. Factor XIII and atherothrombotic diseases. Semin Thromb Hemost 2010;36:18–33.10.1055/s-0030-1248721Search in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston
